Early Day Notes: Micron Technology (NASDAQ:MU), United Online (NASDAQ:UNTD), Xenon Pharmaceuticals (NASDAQ:XENE), Bristol-Myers Squibb Company (NYSE:BMY)

Intel Corporation (NASDAQ:INTC) shares increased 0.13% in last trading session and ended the day at $31.69. INTC Gross Margin is 62.60% and its has a return on assets of 12.00%. Intel Corporation (NASDAQ:INTC) quarterly performance is -7.26%.

On 15 March, Intel Corporation (NASDAQ:INTC) and Exos want to work on the way data recorded by Intel-based fitness products is delivered back to the user. Users of wearables do not get much in the way of actionable data.

On 16 March, Micron Technology, Inc. (NASDAQ:MU) shares decreased -1.20% and was closed at $10.72. MU EPS growth in last 5 year was 6.00%. Micron Technology, Inc. (NASDAQ:MU) year to date (YTD) performance is -24.29%.

Micron Technology, Inc. (NASDAQ:MU) to downtick on near-tern demand and guide to low end of capital-expenditure range, Micron instead put the focus on the longer term, particularly fiscal 2017, when a much lower cost per bit is expected to drive margin expansion.

On 16 March, United Online, Inc. (NASDAQ:UNTD) shares moved up 0.74% and was closed at $12.24. UNTD EPS growth in last 5 year was -43.70%. United Online, Inc. (NASDAQ:UNTD) year to date (YTD) performance is 3.82%.

United Online, Inc. (NASDAQ:UNTD) was upgraded by investment analysts at TheStreet from a “sell” rating to a “hold” rating in a report released on Tuesday,MarketBeat.Com reports.

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) shares decreased -3.39% in last trading session and ended the day at $7.12. XENE has a return on assets of -3.10%. Xenon Pharmaceuticals Inc. (NASDAQ:XENE) quarterly performance is -10.44%.

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) provided an update on its two ongoing collaborations focused on identifying and developing novel pain targets and therapeutics with Genentech.

Bristol-Myers Squibb Company (NYSE:BMY) caters to the Healthcare space. It has a net profit margin of 9.50% and weekly performance is -4.42%. On the last day of trading company shares ended up at $62.64. Bristol-Myers Squibb Company (NYSE:BMY) distance from 50-day simple moving average (SMA50) is -0.74%.

Bristol-Myers Squibb Company (NYSE:BMY) announced that its Board of Directors has elected Peter J. Arduini to the Board, effective April 1, 2016. Mr. Arduini will serve as a member of the Audit Committee of the Board of Directors, effective May 3, 2016.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *